TriSalus Life Sciences's total assets for Q4 2023 were $17.89M, a decrease of -30.46% from the previous quarter. TLSI total liabilities were $52.81M for the fiscal quarter, a 2.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.